Company intelligence / Profile preview

AmeriSciences

Katy, Texas, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

AmeriSciences specialized in science-based product formulation and manufacturing of nutritional supplements under Good Manufacturing Practices (GMP). The company’s products included formulations such as omega-3 fatty acids. It was acquired by Supplement Research and Development, LLC d/b/a AmeriSciences® in 2013.[2][3][9] No current clinical pipeline exists.

Therapeutic areas: Other
Modalities: Small moleculeNutritional supplementOmega-3 fatty acid
Industry: Food & Nutrition

Beyond the preview

Go deeper on AmeriSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AmeriSciences.

Explore the full profile